Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2017
DOI: 10.1016/j.diabres.2017.08.018
|View full text |Cite
|
Sign up to set email alerts
|

Transforming growth factor beta (TGF-β) mediates cardiac fibrosis and induces diabetic cardiomyopathy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
133
0
4

Year Published

2018
2018
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 183 publications
(141 citation statements)
references
References 57 publications
4
133
0
4
Order By: Relevance
“…These findings are consistent with evidence that progressive obesity develops in ob/ ob and db/db mice at 6 months of age, but none of ob/ob mice have LVH at 2 months 2 . LVH is associated with fibrosis, which results in elevated dysferlin that functions in cardiac extracellular membrane repair, and TGF-β1 is www.nature.com/scientificreports www.nature.com/scientificreports/ increased in hyperglycemia in diabetic models 20,21 . Indeed, we found that soluble ST2, a fibrosis biomarker, is elevated in ob/ob mice at 25 weeks of age, which is consistent with findings reported from obese rats, in which serum ST2, collagen type 1, and profibrotic factors were elevated 22 .…”
Section: Discussionmentioning
confidence: 99%
“…These findings are consistent with evidence that progressive obesity develops in ob/ ob and db/db mice at 6 months of age, but none of ob/ob mice have LVH at 2 months 2 . LVH is associated with fibrosis, which results in elevated dysferlin that functions in cardiac extracellular membrane repair, and TGF-β1 is www.nature.com/scientificreports www.nature.com/scientificreports/ increased in hyperglycemia in diabetic models 20,21 . Indeed, we found that soluble ST2, a fibrosis biomarker, is elevated in ob/ob mice at 25 weeks of age, which is consistent with findings reported from obese rats, in which serum ST2, collagen type 1, and profibrotic factors were elevated 22 .…”
Section: Discussionmentioning
confidence: 99%
“…The upregulation of TGF-β1 has been observed in lung, liver and kidney fibrosis [12,16,19]. TGF-β1 has been also identified as a key regulator of cardiac fibrosis [25], which may affect cell growth, apoptosis and differentiation, increase ECM production, maintain fibroblast viability, inhibit metalloproteinase production, and facilitate collagen degradation [26]. TGF-β1 activates Smad-dependent and -independent pathways to exhibit its biological activities [27].…”
Section: Tgf-β1mentioning
confidence: 99%
“…Chronic heart failure (CHF) is characterized by the inability of the heart to maintain a normal cardiac output without invoking maladaptive compensatory mechanisms [63]. Several studies have been explored both Smad-dependent and Smad-independent pathways contributed to cardiac fibrosis in TGF-β-induced signaling pathway [25]. In addition to being involved in canonical Smad signaling, TGF-β was also implicated in Smad-independent pathways, which also involve some members of the MAPK family.…”
Section: Tgf-β/smad Signaling Pathway In Cardiac Fibrosismentioning
confidence: 99%
See 1 more Smart Citation
“…If this modification was blocked, the following steps of TGF-β signaling through the phosphorylation of regulatory Smad2 and Smad3 (R-Smads) would also be terminated [27]. At present, TGF-β was verified as one of the molecular mediators involved in the progression of fibrosis in DCM [28].…”
Section: Introductionmentioning
confidence: 99%